Elevation Pharmaceuticals is a specialist on aerosol-type respiratory galenics and fits into Sunovion, Dainippon Sumitomo’s US daughter company’s portfolio with drugs against chronic obstructive pulmonary diseases (COPD).
Dainippon Sumitomo Pharma press release, August 31, 2012
Dainippon Sumitomo Pharma to acquire US Elevation Pharmaceuticals for 100 million USD